Non-invasive Phrenic Nerve Stimulation in ARDS Patient

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorSoutheast University, China

About this trial

Reduced diaphragmatic activity during mechanical ventilation can lead to diaphragmatic disuse atrophy, atelectasis, increased lung stress and strain, and hemodynamic impairment. This, in turn, may prolong the duration of mechanical ventilation, make weaning more difficult, and even increase mortality. Synchronizing phrenic nerve stimulation to promote diaphragmatic activity may prevent ventilator-induced lung injury and ventilator-induced diaphragm dysfunction, thereby improving patient outcomes. Surgically implanted phrenic nerve stimulation has been used in certain neurological disorders, but the effects of percutaneous non-invasive synchronized phrenic nerve stimulation in patients with ARDS undergoing mechanical ventilation remain unclear and require further investigation.

Eligibility criteria

Qualifiers

Adult ARDS patients undergoing controlled mechanical ventilation

The duration of endotracheal intubation < 48 hrs

Disqualifiers

Neurological condition affecting motor neuron or muscle (e.g. ALS)

Paralysis of the phrenic nerve

Proven or suspected spinal cord injury

Conditions that limit diaphragm movement

Trial design

Treatments tested in this trial

  • PNS group

Treatment groups

10 Participants
are divided into 1 treatment group

Sponsors and collaborators